Aram Kang

672 citations
31 papers · 535 indexed · h-index 14
Topics
Influenza Virus Research Studies (6 papers)Ubiquitin and proteasome pathways (5 papers)RNA Interference and Gene Delivery (3 papers)

In The Last Decade

Aram Kang

29 papers receiving 531 citations

Peers

Aram Kang
Comparison fields: 5 of 92
  • Molecular Biology 203
  • Infectious Diseases 106
  • Pharmaceutical Science 103
  • Immunology 85
  • Biomedical Engineering 82
Replace Omid Gholizadeh with:
Omid Gholizadeh Iran
Alexandra Nikonova Russia
Xiaoyong Yuan China
Sanquan Zhang China
Sujatha Dokka United States
Anupama Sinha United States
Sumita Behera United States
Eleni Maria Varypataki Netherlands
Alyssa Siefert United States
Jiafei Zhu China
Aram Kang relative to Omid Gholizadeh Iran Omid Gholizadeh's profile →
Citations per field
00.5×
Omid Gholizadeh · 1×
Citations per year

Countries citing papers authored by Aram Kang

Since Specialization
Citations

This map shows the geographic impact of Aram Kang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aram Kang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aram Kang more than expected).

Fields of papers citing papers by Aram Kang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aram Kang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aram Kang. The network helps show where Aram Kang may publish in the future.

Co-authorship network of co-authors of Aram Kang

This figure shows the co-authorship network connecting the top 25 collaborators of Aram Kang. A scholar is included among the top collaborators of Aram Kang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aram Kang. Aram Kang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 4
3 0
4 10
5 13
6 7
7 13
8 8
9 13
10 1
11 14
12 17
13 113
14 5
15 84
16 10
17 3
18 13
19 14
20 26

About Aram Kang

Aram Kang is a scholar working on Pharmaceutical Science, Agronomy and Crop Science and Toxicology, having authored 31 papers that have together received 535 indexed citations. Recurring topics across this work include Influenza Virus Research Studies (6 papers), Ubiquitin and proteasome pathways (5 papers) and RNA Interference and Gene Delivery (3 papers). The work is most often cited by research in Pharmaceutical Science (103 citations), Dermatology (53 citations) and Infectious Diseases (106 citations). Aram Kang has collaborated with scholars based in South Korea, United States and Finland. Frequent co-authors include Woonsung Na, Daesub Song, Minjoo Yeom, Hyun‐Ouk Kim, Geunseon Park, Chaewon Park, Seungjoo Haam, Seongman Kang, Jung‐Hwan Park and Seong‐O Choi. Their work appears in journals such as Journal of Biological Chemistry, Biochemical and Biophysical Research Communications and International Journal of Molecular Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026